Leaflet PROHANCE 0.5mmol / ml solution for injection

Product code:
W66183005
Quantity:
1
Indicated for:
diagnostic imaging contrast enhancement
Route of administration:
injectable
Substance:
gadoteridol (contrast agent)
ATC
V08CA04 — Various | Magnetic resonance imaging contrast media | Paramagnetic contrast media

Precautions:

Anaphylaxis

Anaphylaxis

Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.

Additional monitoring

Additional monitoring

This medicine is subject to additional monitoring.

Nephrotoxicity

Nephrotoxicity

This medicine may affect the kidneys.

Gadoteridol is a contrast agent used in magnetic resonance imaging (MRI) to enhance the visualization of internal structures, including the brain, spine, and other organs. It is a gadolinium-based contrast agent.

This medication is administered intravenously and is used for diagnosing neurological, vascular, or oncological conditions.

Adverse reactions may include nausea, dizziness, headache, or injection site reactions. In rare cases, severe allergic reactions or nephrogenic systemic fibrosis may occur in patients with kidney impairment.

It is important to discuss your medical history, especially kidney conditions, with your doctor before receiving gadoteridol.

General data about PROHANCE 0.5mmol / ml

Substance:
gadoteridol
Date of latest medicines list:
01-06-2026
Product code:
W66183005
Concentration:
0.5mmol / ml
Pharmaceutical form:
solution for injection
Quantity:
1
Product type:
Original
Price:
214.36 RON
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
BRACCO IMAGING S.P.A. - ITALIA
Holder:
BRACCO IMAGING S.P.A. - ITALIA
Number:
11933/2019/05
Shelf life:
3 years; After first opening the bottle. - it is used immediately

Pharmaceutical forms available for gadoteridol